[
    [
        {
            "time": "",
            "original_text": "甘李药业：在研药GLR2007获FDA快速通道认定 研发进程再提速",
            "features": {
                "keywords": [
                    "甘李药业",
                    "GLR2007",
                    "FDA",
                    "快速通道",
                    "研发进程"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "甘李药业：在研药GLR2007获FDA快速通道认定 研发进程再提速",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "甘李药业(603087.SH)：在研产品GLR2007获美国FDA快速通道资格",
            "features": {
                "keywords": [
                    "甘李药业",
                    "GLR2007",
                    "美国FDA",
                    "快速通道",
                    "在研产品"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "甘李药业(603087.SH)：在研产品GLR2007获美国FDA快速通道资格",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]